Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-020985-94Phase 3Completed
Phase 3, randomised, double-blind trial of amylmetacresol + 2,4-dichlorobenzyl alcohol in pharyngitis (2 arms), sponsored by Reckitt. Primary endpoint: Area under the change from baseline curve in severity of throat soreness from 0 to 2 hours. Started Aug 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-020985-94.